Home > Press > Northeastern Scientist Receives Prestigious PSWC Award
Northeastern scientist Vladimir Torchilin will receive a Research Achievement Award at the 2007 Pharmaceutical Sciences World Congress (PSWC) for his contributions to pharmaceutical science, which include achievements in nanomedicine and drug targeting.
Northeastern Scientist Receives Prestigious PSWC Award
BOSTON, MA | Posted on February 7th, 2007
Long before becoming an award-winning scientist, Northeastern University professor Vladimir Torchilin exhibited the potential to do great things as a teenager in Russia. At only 16 years of age, he gained early admission to Moscow State University, where he advanced quickly, earning his undergraduate degree, masterís degree, and Ph.D. in 10 years.
Torchilin progressed in just three years from junior scientist at Moscow State to senior scientist at the former Soviet Unionís Academy of Medical Science. During this period, he also became one of the youngest recipients ever of the prestigious Lenin Prize in Science and Technology.
Shortly before the break-up of the Soviet Union, Torchilin left Russia in 1990 for the United States, where he held various academic and research positions, including a successful joint appointment with Harvard Medical School and Massachusetts General Hospital. He now serves as chair of Northeasternís Pharmaceutical Sciences Department and director of the Center for Pharmaceutical Biotechnology and Nanomedicine.
Torchilin will add to this impressive roster of accomplishments this April in Amsterdam, where he will accept the prestigious Research Achievement Award at the 2007 Pharmaceutical Sciences World Congress (PSWC), the worldís largest assembly of pharmaceutical scientists and professionals. During the eventís opening ceremony, he will be honored by thousands of peers for a lifetime of significant contributions to the global advancement of pharmaceutical science.
Torchilinís most recent work involves treating cancer with tiny capsules filled with chemotherapy, which are delivered into a tumorís cells through its blood vessels, where they release drugs without damaging other parts of the body. He is internationally recognized for research in drug targeting, delivery systems, and nanomedicine, having secured more than 45 patents and published more than 300 papers, reviews, and book chapters, along with eight books.
"It is a true honor to be recognized by the Pharmaceutical Sciences World Congress," said Professor Torchilin. "At the same time, there is much work to be done. As life expectancies increase, important pharmaceutical advances are necessary for improving quality of life. My goal is to develop more perfect methods of treatment that fight illness with precision, so people can live longer lives in comfort and good health."
About Northeastern University
Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern is a leader in interdisciplinary research, urban engagement, and the integration of classroom learning with real-world experience. The universityís distinctive cooperative education program, where students alternate semesters of full-time study with semesters of paid work in fields relevant to their professional interests and major, is one of the largest and most innovative in the world. The University offers a comprehensive range of undergraduate and graduate programs leading to degrees through the doctorate in six undergraduate colleges, eight graduate schools, and two part-time divisions. For more information, please visit http://www.northeastern.edu .
For more information, please click here
Copyright © Northeastern University
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Arrowhead to Report Fiscal 2014 Third Quarter Financial Results- Conference Call Scheduled for Tuesday, August 12, 2014 - July 31st, 2014
New imaging agent provides better picture of the gut July 30th, 2014
Zenosense, Inc. July 29th, 2014
Optimum inertial design for self-propulsion: A new study investigates the effects of small but finite inertia on the propulsion of micro and nano-scale swimming machines July 29th, 2014
Industrial Nanotech, Inc. to Publish PCAOB Audited Financials July 31st, 2014
Nanostructured metal-oxide catalyst efficiently converts CO2 to methanol: Highly reactive sites at interface of 2 nanoscale components could help overcome hurdle of using CO2 as a starting point in producing useful products July 31st, 2014
Carnegie Mellon Chemists Create Nanofibers Using Unprecedented New Method July 31st, 2014
Pressure probing potential photoelectronic manufacturing compound July 31st, 2014
Japanese gold leaf artists worked on a nano-scale: Study demonstrates X-ray fluorescence spectroscopy is a non-destructive way to date artwork July 3rd, 2014
Harry Potter-style invisibility cloaks: A real possibility next Christmas? Forget socks and shaving foam, the big kids of tomorrow want an invisible cloak for Christmas December 19th, 2013
Chicago Awareness Organization First Not-for-Profit to Sponsor Dog Training to Detect Ovarian Cancer Odorants December 12th, 2013
ZEISS Microscopes used to create images for Art Exhibit at Midway Airport: Art of Science: Images from the Institute for Genomic Biology October 25th, 2013
New imaging agent provides better picture of the gut July 25th, 2014
Hysitron is Awarded TWO R&D 100 Awards for Highly Innovative Technology Developments in the Areas of Extreme Environments and Biological Mechanical Property Testing July 23rd, 2014
Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014
EPFL Research on the use of AFM based nanoscale IR spectroscopy for the study of single amyloid molecules wins poster competition at Swiss Physics Society meeting July 22nd, 2014